Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques 

Published byGerald Conley Modified over 5 years ago

Similar presentations

Presentation on theme: "Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques "— Presentation transcript:

1 Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques  Christine E. Hill-Kayser, MD, Stephen Avery, PhD, Carmen F. Mesina, MS, Paul James, CMD, Joseph S. Friedberg, MD, Keith Cengel, MD, PhD, Lilie L. Lin, MD, Stephen M. Hahn, MD, Ramesh Rengan, MD, PhD  Journal of Thoracic Oncology  Volume 4, Issue 11, Pages (November 2009) DOI: /JTO.0b013e3181b9eb85 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Planning target volume (PTV) used for intensity-modulated radiotherapy (IMRT) planning for hemithoracic radiotherapy after extrapleural pneumonectomy. PTV included the entire chest cavity and chest wall and adjacent abdomen from the level of the thoracic inlet to the diaphragmatic insertion as delineated by surgical clips. Treatment volumes were extended to encompass skin in regions of scar and drain sites. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Sample beam arrangement and dose distribution for delivery of intensity-modulated radiation therapy (IMRT) to the (A) left and (B) right hemithorax after extrapleural pneumonectomy in treatment of malignant mesothelioma. Treatment consisted of delivery of 45 Gray (Gy) in daily fractions of 1.8 Gy to the planning target volume (PTV). Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Field and block arrangements employed with use of combined electron-photon technique for hemithoracic radiotherapy after extrapleural pneumonectomy. The total prescribed dose from the anterior-posterior (AP-PA) photon fields and supplemental electron fields was 54 Gray (Gy) in 1.8 Gy fractions. At the initiation of treatment, blocks were placed in the region of the abdomen. During treatment of the left hemithorax, an anterior block was placed over the heart at 19.8 Gy. Blocked areas were subsequently delivered 1.53 Gy daily through an en face electron field. At 41.4 Gy, anterior and posterior blocks were placed over the spinal cord. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Average percent of prescribed dose to planning target volume with electron-photon technique (EPT) versus intensity-modulated radiotherapy (IMRT) during hemithoracic radiotherapy after extrapleural pneumonectomy. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Average contralateral lung volume receiving dose of 5 Gray (Gy) and 20 Gy with electron-photon technique (EPT), prescribed to 54 Gy, versus intensity-modulated radiotherapy (IMRT), prescribed to 45 Gy, during hemithoracic radiotherapy after extrapleural pneumonectomy. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

7 FIGURE 6 Dose to organs at risk with electron-photon technique (EPT) versus intensity-modulated radiotherapy (IMRT) for hemithoracic radiotherapy after extrapleural pneumonectomy. *Median heart dose for only patients receiving left-sided treatment (n = 5). **Median liver dose for only patients receiving right-sided treatment (n = 5). CL, contralateral lung; IK, ipsilateral kidney; and CK, contralateral kidney. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181b9eb85) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques "

Similar presentations

Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.

Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
A Hole in the Heart Journal of Thoracic Oncology

A Hole in the Heart Journal of Thoracic Oncology
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 
Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia  Arman Hasani, MBBS, FRACP, John M. Alvarez,

Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia  Arman Hasani, MBBS, FRACP, John M. Alvarez,
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.

Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.
Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction 

Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction 
Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making 

Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making 
Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.

Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.
Insert tables Insert figure

Insert tables Insert figure
Insert tables Insert graphs Insert figure

Insert tables Insert graphs Insert figure
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma  Marc de Perrot, MD, MSc, Ronald Feld, MD,

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma  Marc de Perrot, MD, MSc, Ronald Feld, MD,
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,

Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.

Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Insert tables Insert graphs Insert figure

Insert tables Insert graphs Insert figure
Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging  Amish P. Shah, PhD, Tomas Dvorak,

Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging  Amish P. Shah, PhD, Tomas Dvorak,
A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer:

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer:

Similar presentations

Ads by Google